Lucid Diagnostics Inc. (LUCD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 2.2200 |
| Open | 2.2500 |
| Bid | 0.0000 x 1300 |
| Ask | 0.0000 x 1000 |
| Day's Range | 2.1900 - 2.3250 |
| 52 Week Range | 1.7900 - 13.5200 |
| Volume | |
| Avg. Volume | 171,949 |
| Market Cap | 85.048M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
NEW YORK, May 13, 2022--PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO.
- Business Wire
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
NEW YORK, May 11, 2022--Lucid Diagnostics provides business update and preliminary first quarter 2022 financial results.
- Business Wire
Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
NEW YORK, May 09, 2022--Lucid’s first commercial payer agreement provides in-network access and payment for its EsoGuard® DNA test to over 8 million covered lives.
© 2022 Yahoo. All rights reserved.
